Everything you need to track the market
Comprehensive tools for monitoring the stem cell therapy landscape
Real-time Revenue Tracking
Monitor quarterly and annual revenue data from leading cell therapy companies.
Regulatory Approval Monitoring
Track FDA, EMA, and other global regulatory approvals as they happen.
Treatment Center Mapping
Visualize global treatment centers and their capabilities on interactive maps.
Market Analytics
Deep insights into market trends, therapy costs, and patient volumes.
Industry Insights
Access the latest reports and insights from industry and academic experts.
Instant Updates
Get notified of new approvals, revenue reports, and market changes.
Preview Market Data
Get a glimpse of our comprehensive analytics platform
Market Analytics Dashboard
Interactive charts showing revenue trends, regulatory approvals, and market insights
Cell Therapy Revenue Analysis
Interactive line chart with date range slider showing revenue and patient volume trends. Filter by time period, regions, and therapies.
View:
Time Resolution:
Date Range:Q1 2020 - Q1 2020
Q1 2020Q4 2024
Regions:
Global
United States
Other
Europe
Therapies:
Kymriah
Breyanzi
Aucatzyl
Carteyva
Tecartus
Yescarta
Carvykti
Abecma
Fucaso
Kymriah
118.5M
Total Revenue
Breyanzi
0.0M
Total Revenue
Aucatzyl
0.0M
Total Revenue
Carteyva
0.0M
Total Revenue
Tecartus
11.0M
Total Revenue
Yescarta
140.8M
Total Revenue
Carvykti
0.0M
Total Revenue
Abecma
0.0M
Total Revenue
Fucaso
0.0M
Total Revenue
Regulatory Approvals by Product
Number of regulatory approvals for each therapy, stacked by regulatory body. Filter by approval type and disease indication.
Approval Type:
Full Approval
Conditional Approval
Accelerated Approval
Disease Indication:
DLBCL
FL
Pediatric-B-ALL
LBCL-Second-Line
PMBCL
MCL
Adult-B-ALL
CLL/SLL
MM
NDMM
RRMM
Approved Products by Disease
Number of approved therapeutic products for each disease indication, stacked by manufacturer. Filter by region and mechanism of action.
Regions:
United States
European Union
United Kingdom
China
Mechanism:
CAR-T
Treatment Cost Comparison
Cost per treatment for different CAR-T therapies approved for selected disease indications.
Disease Indication:
DLBCL
FL
Pediatric-B-ALL
LBCL-Second-Line
PMBCL
MCL
Adult-B-ALL
CLL/SLL
MM
NDMM
RRMM
Loading map...